Purpose: In contemporary time, breast cancer has been extensively found among women at a global rate of 24.2% as of 2018. This exposes the significant and imperative need for detecting masses and micro calcifications in the breast to avoid death rates. The existing histopathological images have gained a golden standard considering they would afford reliable results. However, these images have been entangled with various complexities including insufficient image contrast, noise, and misdiagnosis. These pitfalls might negatively impact the detection rate for which automatic recognition has become vital. With the momentous evolvement of Machine Learning (ML) and Deep Learning (DL), various researchers have endeavoured to consider ML and DL for accomplishing this prediction. However, they need to improve in accuracy rate due to ineffective feature extraction, and most studies averted to consider segmentation. Hence, this study regards accomplishing a high classification and segmentation process. Materials and Methods: The study proposes Modified Weight Updated Convolutional Block-U-Net (MWuConv-U-Net) to handle the image dimensions optimally. In this case, U-Net based model is regarded by improvising it with the inclusion of an additional convolutional layer in individual encoder-decoder. Further, the study proposes an Optimized Weight Updated eXtreme Gradient Boosting-Support Vector Machine (OWuXGBoost-SVM) for determining the optimal gradient, which would eventually enhance the prediction rate. Results: The overall performance is assessed through performance metrics to confirm its effectiveness in classifying and segmenting the Breast Cancer Histopathological (BACH) image dataset. Comparison is undertaken with conventional systems in accordance with metrics (recall, F1-score, precision, and accuracy). The results revealed the efficacy of the proposed system with 99% accuracy, 99% F1-score, 99% precision, and 99% recall. Conclusion: High accuracy procured through the analysis reveals its efficacy and hence it could be applicable for real-time execution for assisting medical experts in early breast cancer prognosis. © 2024 Elsevier B.V., All rights reserved.